Collectively, these results establish the 3‐gene (ENAH, AXL and GAS6) expression signature as a prognostic indicator, hallmark of an aggressive disease in PDAC and LUSC patients and strengthen the clinical relevance of the hMENA expression pattern analysis in both tumor cells and CAFs. Here, ENAH is linked to neoplasm.